Previous 10 | Next 10 |
home / stock / crtpf / crtpf news
Cardiol Therapeutics ( OTCPK:CRTPF ) has signed a supplier agreement to offer its pharmaceutically produced cannabidiol to Medical Cannabis by Shoppers, a subsidiary of Shoppers Drug Mart. More news on: Cardiol Therapeutics Inc., Healthcare stocks news, Read more ...
Oakville, Ontario--(Newsfile Corp. - March 18, 2020) - Cardiol Therapeutics Inc. ( TSX: CRDL ) ( OTCQX: CRTPF ) (" Cardiol " or the " Company "), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol products for heart disease, is ...
Oakville, Ontario--(Newsfile Corp. - January 15, 2020) - Cardiol Therapeutics Inc. ( TSX: CRDL ) ( OTCQX: CRTPF ) (" Cardiol " or the " Company "), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol medicines for heart disease, is pl...
The medical world has only just begun to tap into the potential of cannabinoid-based medicines, including cannabidiol (CBD). CBD is widely being used for mild pain relief and as a general wellness product, but the potential medical utility could go much deeper. At least one CBD product has ...
As we get to the end of 2019, a somewhat trying year for the cannabis sector, investors are looking to see which cannabis stocks managed to pull ahead of their competition during the year. Though 2018 was defined by quick gains, this year the entire marijuana sector was under pressure as the...
Oakville, Ontario--(Newsfile Corp. - December 3, 2019) - Cardiol Therapeutics Inc. ( TSX: CRDL ) ( OTCQX: CRTPF ) (" Cardiol " or the " Company "), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol medicines for heart disease, is...
According to industry leaders, CBD testing is necessary to ensure safety and consistency in the cannabis pharmaceutical industry. Cannabinoid-based medicine is now more popular than ever and gaining newfound legitimacy. With that legitimacy, however, comes responsibility. The era of the ...
Oakville, Ontario--(Newsfile Corp. - November 25, 2019) - Cardiol Therapeutics Inc. ( TSX: CRDL) ( OTCQX: CRTPF ) (" Cardiol " or the " Company "), a leader in the production of pharmaceutical cannabidiol ("CBD") products and in the development of innovative cannabidiol medicines for ...
Oakville, Ontario--(Newsfile Corp. - November 19, 2019) - Cardiol Therapeutics Inc. ( TSX: CRDL) (OTCQX: CRTPF ) (" Cardiol " or the " Company "), a leader in the production of pharmaceutical cannabidiol (CBD) products and in the development of innovative cannabidiol medicines for heart diseas...
Oakville, Ontario--(Newsfile Corp. - October 1, 2019) - Cardiol Therapeutics Inc. ( TSX: CRDL) (OTCQX: CRTPF ) ("Cardiol" or the "Company"), a leader in the production of pharmaceutical CBD products and in the development of innovative CBD medicines for heart disease, announces that it has com...
News, Short Squeeze, Breakout and More Instantly...
Cardiol Therapeutics Company Name:
CRTPF Stock Symbol:
OTCMKTS Market:
Oakville, Ontario--(Newsfile Corp. - August 9, 2021) - Cardiol Therapeutics Inc. ( TSX: CRDL ) (" Cardiol " or the " Company "), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease, announced to...
Oakville, Ontario--(Newsfile Corp. - July 7, 2021) - Cardiol Therapeutics Inc. ( TSX: CRDL ) ( OTCQX: CRTPF ) ( FSE: CT9 ) (" Cardiol " or the " Company "), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardio...
Oakville, Ontario--(Newsfile Corp. - June 30, 2021) - Cardiol Therapeutics Inc. ( TSX: CRDL ) ( OTCQX: CRTPF ) ( FSE: CT9 ) (" Cardiol " or the " Company "), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardi...